Clinical Trials Evidence for Ivermectin in COVID-19

Share on facebook
Share on whatsapp
Share on twitter
Share on email

Ivermectin, an anti-parasitic medicine whose discovery won the Nobel Prize in 2015, has proven, highly potent, anti-viral and anti-inflammatory properties in laboratory studies.

In the past 4 months, numerous, controlled clinical trials from multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with ivermectin. Our comprehensive scientific review of these referenced trials can be found on the Open Science Foundation pre-print server here:

Join our
Mailing List

* indicates required
/ ( mm / dd )